Preclinical and clinical evaluation of the siddha classical drug ATHIMADHURA KULIGAI(oral administration) along with KADUGU ENNAI (external application) in the management of AUTISM SPECTRUM DISORDER.

Preclinical and clinical evaluation of effect on oral administration of ATHIMADHURA KULIGAI along with external application KADUGU ENNAI in the management of MAANTHASANNI

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/02/039889

Enrollment

Registered

2022-02-01

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F840- Autistic disorder

Interventions

Intervention1: ATHIMADHURA KULIGAI: 1 pill twice a day with honey for 45 days. Intervention2: KADUGU ENNAI: Thuvalai 45days Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children have lack of eye contact 2.lack of response 3.Repeatative or restricted behaviour 4.Unawareness of natural urges 5.Acquired speech or lost it 6.Unusual senstivity to sensory stimuli

Exclusion criteria

Exclusion criteria: 1.Children above 12 years 2.Children below 2 years 3.Seevere and recurrent seizures 4.ADHD 5.CP 6.Infantile hemiplegia 7.Congenital anomalies

Design outcomes

Primary

Measure	Time frame
Managing clinical symptomsTimepoint: 45 days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr K Shyamala MDs

Government Siddha Medical College and Hospital

shyamsujisathya@gmail.com9442277124

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026